Fibrinolytic therapy in unstable angina pectoris. A controlled clinical trial.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents; D014859:Warfarin; D013300:Streptokinase